Further investigation with TCGA [21] and the Kaplan-Meier databases [22] indicated that the 10 hub genes except KLHL35 were increased both in the treatment with bufadienolide-like chemicals and the TCGA breast cancer sample (Figure 9C). This evidence concerns the gene KLHL35 and breast cancer.